Project Grant F31AI194791
- Federal Project Grant Award Summary Albert Einstein College of Medicine received a $780,787 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded January 27, 2026, with completion targeted for December 31, 2030. The grant funds fundamental immunological research to understand how T cell receptor (TCR) recognition of peptide ligands shapes the development and programming of memory CD8+...
- Federal Grant Award Summary Albert Einstein College of Medicine received a $462,000 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded July 7, 2025, with completion targeted for June 30, 2027. The research initiative focuses on designing improved T cell epitopes (antigenic peptides) to enhance the efficacy of T cell-based vaccines and adoptive cell therapies. The project will...
- Federal Grant Award Summary Albert Einstein College of Medicine received a $3.2 million Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded June 18, 2026, with completion targeted for May 31, 2030. The award supports biomedical research investigating the interaction between TAR (trans-activation response) RNA and INI1/SMARCB1, a component of chromatin remodeling complexes critical...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Albert Einstein College of Medicine a $2.46 million Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective September 1, 2025, through August 31, 2029. This award funds investigator-initiated biomedical research focused on Toxoplasma gondii-associated encephalitis in people living with HIV/AIDS (PLWHA). The research project addresses the...
- Federal Grant Award Summary Albert Einstein College of Medicine received a $100,228 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective December 4, 2026, with an ultimate completion date of June 30, 2029. This F31 fellowship grant supports doctoral-level research training and investigation into the role of Plasmodium-specific cytolytic CD4+ T cells in malaria immunity. The...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded New York University School of Medicine a Project Grant totaling $508,500 under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective April 22, 2026, with a completion date of March 31, 2031. This postdoctoral research award supports fundamental investigation into the molecular mechanisms by which myeloid cells—specifically neutrophils—regulate plasma membrane...
- Federal Project Grant Award Summary New York University School of Medicine received a $755,801 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 3, 2026, with a completion date of January 31, 2031. The grant funds biomedical research investigating the regulation of CD4+ and CD8+ T cell function by CLNS1A, a protein that controls immune cell proliferation and...
- Federal Grant Award Summary New York University School of Medicine received a $808,523 Project Grant from the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective June 1, 2026, with completion targeted for May 31, 2031. The award funds research investigating the role of the FLI1 transcription factor in T follicular helper (TFH) cell differentiation and humoral immunity. The project examines how calcium...
- Federal Grant Award Summary New York University School of Medicine received a $250,000 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded August 6, 2025, with a completion date of July 31, 2029. The project will develop a structural causal framework for adaptive randomized clinical trials in infectious disease research, addressing critical methodological gaps in the design and...
- Federal Project Grant Award Summary Tufts University School of Medicine received a $156,080 Project Grant awarded on January 29, 2026, by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award supports research to elucidate spatio-temporal innate immune cell modulation of Mycobacterium tuberculosis (MTB) stress response and replication heterogeneity through August 15, 2028. The research investigates...
Grant Award Summary Albert Einstein College of Medicine received a $100,228 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded December 8, 2026, with completion targeted for March 31, 2028. This research initiative, titled "Deciphering the Mechanisms That Regulate Neutrophil Recruitment and Function in Polytraumatic Injury," delivers basic biomedical research services focused on understanding immune response dysregulation following multiple concurrent injuries. The project employs transgenic zebrafish models with fluorescently tagged neutrophils to visualize and track neutrophil recruitment and function at the single-cell level in polytraumatic injury contexts, advancing understanding of how immune dysfunction—particularly in patients with pre-existing metabolic disorders such as diabetes and obesity—contributes to secondary complications including nosocomial infections, impaired wound healing, and multi-organ dysfunction. The research deliverables include mechanistic data on neutrophil signaling pathways in response to damage-associated molecular patterns (ATP, calcium), comparative analysis of neutrophil recruitment patterns between single and polytraumatic injury models, and foundational knowledge applicable to improving clinical outcomes for trauma patients at high immunological risk. Research is conducted at the institution's Bronx, New York location and aligns with NIAID's broader portfolio supporting innovative infectious disease and immunological research that addresses urgent public health challenges.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 6/9/26 | ||
| Not listed | $50.1k | 6/9/26 | ||
| Not listed | $50.1k | 6/9/26 |